slides · global inventory
Sparkline
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 22,963
Current window 14,071-14,100
Pages 766
Rows per page 30
Arc
14,071-14,100 of 22,963
15
The table includes adjustments for equity compensation, acquisition-related expenses, revaluation of earnout consideration, separation expenses, and facility start-up costs.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · Appendix1 hit
16
Financial statement presentation; unaudited.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · Appendix1 hit
17
The table displays financial performance metrics including net sales, gross profit, operating profit, and net income, alongside per-share data.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · Appendix1 hit
18
Amounts in $000's.Lakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · Appendix1 hit
19
Lakeland Bancorp | Investor Conference Presentation Deck | 19 slidesLakeland Bancorp | Investor Conference Presentation Deck | 19 slides · Lakeland
Conference presentation Investor relations Beat · Appendix1 hit
01
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Setup1 hit
02
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Setup1 hit
03
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Setup1 hit
04
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Setup1 hit
05
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
06
The table compares clinical outcomes including ORR, CR, PFS, OS, DOR, and safety metrics like CRS, Neurotoxicity, and ICANS across different patient populations.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
07
The slide uses a before-after style transition (Heavily Pre-Treated to Earlier Lines) to frame the expansion strategy.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
08
The chart shows a stacked bar chart comparing U.S. and Ex-U.S. sales over five quarters.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
09
The slide uses color-coded bars to indicate geographic focus (Global, US, China) for each clinical program.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
10
The slide uses bar charts to show year-over-year growth or change percentages between periods.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
11
The slide includes a disclaimer at the bottom and a sidebar with capital raise details.Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
12
The chart shows a bridge from 114M to 145M, with a 27M increase in R&D and a 4M increase in SG&A (net of S&D decrease).Legend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Key Performance Indicators Overview1 hit
13
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · RoadmapLoop · Why Now1 hit
14
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Reflection1 hit
15
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Reflection1 hit
16
Legend Biotech | Results Presentation Deck | 16 slidesLegend Biotech | Results Presentation Deck | 16 slides · Legend Biotech
Conference presentation Investor relations Beat · Closing Ask1 hit
01
ModivCare | Results Presentation Deck | 19 slidesModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Attention1 hit
03
Includes YoY and QoQ growth metrics alongside segment-specific financial results.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Interest1 hit
04
NEMT stands for Non-Emergency Medical Transportation.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Interest1 hit
05
Includes a table of financial metrics and operating metrics, alongside qualitative commentary on performance drivers.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Interest1 hit
06
ModivCare | Results Presentation Deck | 19 slidesModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Interest1 hit
07
The chart uses a standard waterfall bridge format to explain cash flow movements.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit
08
The slide uses a waterfall bridge to reconcile cash from 2Q23 to YE23F.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit
10
Includes leverage metrics based on Consolidated Adj. EBITDA of $214.0 million plus pro forma cost savings, net of future investments of $23.5 million.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit
11
The bridge chart visualizes the impact of NEMT Volume, Trip Mix, and Contract Delays on the EBITDA guidance.ModivCare | Results Presentation Deck | 19 slides · ModivCare
Conference presentation Investor relations Beat · Evidence1 hit